SEC Form 4 · accession 0001104659-15-001306
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Padmanabh P. Bhatt
Officer — SR VP of IP, CSO
Period of report
Jan 5, 2015
Accepted (ET)
Jan 8, 2015 · 7:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 5, 2015 | M | 12,500 | $0.40 | A | 64,306 | D | |
| Common Stock | Jan 5, 2015 | M | 3,000 | $0.40 | A | 67,306 | D | |
| Common Stock | Jan 5, 2015 | M | 2,500 | $3.36 | A | 69,806 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.40 | Jan 5, 2015 | M | 12,500 | D | — | Jan 17, 2016 | Common Stock | 12,500 | 0 | D |
| Employee Stock Option (Right to Buy)F2 | $0.40 | Jan 5, 2015 | M | 3,000 | D | — | Feb 13, 2017 | Common Stock | 3,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $3.36 | Jan 5, 2015 | M | 2,500 | D | — | Feb 10, 2020 | Common Stock | 2,500 | 0 | D |
Explanation of responses
- F1The option became exercisable in four equal installments beginning on January 17, 2007, which was the first anniversary of the date on which the option was granted.
- F2The option became exercisable in four equal installments beginning on February 13, 2008, which was the first anniversary of the date on which the option was granted.
- F3The option became exercisable in four equal installments beginning on February 10, 2010, which was the first anniversary of the date on which the option was granted.